Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Kolo Medical to launch new SiliconWave ultrasound transducers

Kolo Medical is set to introduce new SiliconWave transducers, which can be used for medical ultrasound imaging.

The company will introduce three new SiliconWave transducers at the 2016 IEEE International Ultrasonics Symposium (IUS) in Tours, France. The event will take place from 18 to 21 September.

Compatible with existing and next generation ultrasound systems, the SiliconWave transducer technology offers ultra-high resolution and ultra-wide bandwidth imaging for applications such as thyroid, breast, small parts, musculoskeletal, vascular and dermal imaging.

The new L38-22 linear array transducer, which has a center frequency of 30MHz, provides superficial imaging in the emerging application of dermatology.

It can also be used to image superficial tendons and nerves, in addition to the joints of the wrist, hands, and feet.

With a 120% bandwidth and frequencies from 4 MHz to 17 MHz, the new M17-4 1.5D array transducer has been developed for imaging small parts. It can also be used for deep vascular applications.

The company has developed new L30-14 linear array transducer to be used for neonatal, pediatric, and MSK applications. It has a center frequency of 22MHz.

Kolo Medical is currently working with various OEM partners to test SiliconWave transducers with commercial ultrasound systems.

Kolo Medical president Dr Yongli Huang said: "This provides an opportunity to evaluate our advanced semiconductor technology for use in clinical imaging as well as its current use in research and academic institutions.

"We expect these evaluations will confirm the ability of SiliconWave technology to deliver a new standard of diagnostic imaging. With our OEM partners, we are developing this higher level of performance with a joint goal of improving patient outcomes."